Article Text
Abstract
Objective Barrett's oesophagus (BE) is a metaplastic condition of the distal oesophagus which predisposes to oesophageal adenocarcinoma (EAC). It has been suggested that microRNAs (miRNAs) are involved in the process of development of BE and EAC; however, few functional miRNA data are available. The aim of the study was to perform a tissue-specific miRNA profile and, based on this, to examine the function of miRNA-145 in the oesophagus.
Design miRNA expression profiling using microarray analysis in EAC, BE and normal squamous epithelium of the oesophagus (SQ) was performed and validated using real-time PCR in samples from 15 patients and in situ hybridisation in samples from 10 patients. The proliferative effect of miRNA-145 precursor transfection in the SQ (HET-1A) and BE cell line (BAR-T) was measured. Downstream targets of miRNA-145 were determined by analysing mRNA and protein expression from miRNA-145 transfected cells.
Results Three unique miRNA expression profiles were found in tissue from EAC, BE and SQ, which showed that miRNA-145 was upregulated in BE compared with EAC and SQ. Overexpression of miRNA-145 in HET-1A and BAR-T cells reduced cell proliferation and inhibited GATA6, BMP4 and SOX9 mRNA expression. Furthermore, altered BMP4 signalling was observed in vitro on miRNA-145 overexpression. These effects were blocked when cells were co-transfected with a miRNA-145 specific inhibitor. Additionally, BMP4 incubation of HET-1A cells altered miRNA-145 and GATA6 expression over time.
Conclusion These results imply that miRNA-145 indirectly targets BMP4 via GATA6 and is potentially involved in the development of BE.
- Barrett's oesophagus
- microRNA profiling
- microRNA-145
- bone morphogenetic protein 4
- cell signalling
- Barrett's metaplasia
- Barrett's carcinoma
- Barrett's oesophagus
- gene expression
- Barrett's carcinoma
- Barrett's oesophagus
- carcinogenesis
- molecular pathology
- molecular oncology
- molecular carcinogenesis
- gastric adenocarcinoma
- gastric metaplasia
- gastrointestinal pathology
- pre-malignancy—GI tract
- helicobacter pylori—damage
- hepatitis
- endoscopy
- colorectal carcinoma
- quality of life
- oesophageal cancer
- palliation of oesophageal cancer
- oesophageal disease
- brachytherapy
- stents
Statistics from Altmetric.com
- Barrett's oesophagus
- microRNA profiling
- microRNA-145
- bone morphogenetic protein 4
- cell signalling
- Barrett's metaplasia
- Barrett's carcinoma
- Barrett's oesophagus
- gene expression
- Barrett's carcinoma
- Barrett's oesophagus
- carcinogenesis
- molecular pathology
- molecular oncology
- molecular carcinogenesis
- gastric adenocarcinoma
- gastric metaplasia
- gastrointestinal pathology
- pre-malignancy—GI tract
- helicobacter pylori—damage
- hepatitis
- endoscopy
- colorectal carcinoma
- quality of life
- oesophageal cancer
- palliation of oesophageal cancer
- oesophageal disease
- brachytherapy
- stents
Footnotes
Funding PDS received unrestricted research grant support from AstraZeneca BV and Janssen BV.
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval Ethical approval was obtained from the Medical Ethical Committees of the UMC Utrecht, The Netherlands and University of Padova, Italy.
-
Provenance and peer review Not commissioned; externally peer reviewed.
-
Data sharing statement All authors have read the manuscript, agree to its submission and are willing to share the data written in this manuscript.